NCT05887466: Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients |
|
|
| Active, not recruiting | 1/2 | 12 | RoW | Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) Low Dose, Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) High Dose | S.Biomedics Co., Ltd., Yonsei University | Parkinson's Disease | 02/24 | 02/26 | | |
NCT06477744: Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of A9-DPC in SB-PD-001 Study |
|
|
| Active, not recruiting | N/A | 12 | RoW | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_Low Dose, Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_High Dose | S.Biomedics Co., Ltd., Severance Hospital | Parkinson's Disease | 02/29 | 06/29 | | |
